Kapil Gupta

Providing strategic advisory to biotech startups on biologics drug development, USP/DSP optimization, and CMC readiness.

Conducting technical due diligence, evaluating the scalability of protein-based therapeutic platforms.

Advising on tech-transfer strategies and CDMO selection to de-risk early-stage clinical programs.

Led/managed the team involved in process development of company's propriety VLP platform against various disease targets.

Led and contributed to development of self-assembling protein vaccine platforms, scalable expression and purification strategies, assay development, and successful technology transfer to CDMO.